Design of chimeric histone deacetylase- and tyrosine kinase-inhibitors: a series of imatinib hybrides as potent inhibitors of wild-type and mutant BCR-ABL, PDGF-Rbeta, and histone deacetylases (Q39870406)
Jump to navigation
Jump to search
scientific article published on April 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Design of chimeric histone deacetylase- and tyrosine kinase-inhibitors: a series of imatinib hybrides as potent inhibitors of wild-type and mutant BCR-ABL, PDGF-Rbeta, and histone deacetylases |
scientific article published on April 2009 |
Statements
1 reference
Design of chimeric histone deacetylase- and tyrosine kinase-inhibitors: a series of imatinib hybrides as potent inhibitors of wild-type and mutant BCR-ABL, PDGF-Rbeta, and histone deacetylases (English)
1 reference
Siavosh Mahboobi
1 reference
Stefan Dove
1 reference
Andreas Sellmer
1 reference
Matthias Winkler
1 reference
Emerich Eichhorn
1 reference
Herwig Pongratz
1 reference
Thomas Ciossek
1 reference
Thomas Baer
1 reference
Thomas Maier
1 reference
Thomas Beckers
1 reference
1 April 2009
1 reference
1 reference
Identifiers
1 reference